Skip to main content
Premium Trial:

Request an Annual Quote

False-Marking Lawsuit Against Nucleic Acid Analysis Tool Providers Dropped


Patent watchdog firm Troll Busters has chosen to abandon its lawsuit against more than a dozen life science companies for false patent marking related to various nucleic acid detection, amplification, and cloning technologies, according to recently filed court documents.

The US District Court for the Southern District of California, which had been hearing the case, last week granted Troll Busters' motion to dismiss, which was filed earlier in October.

Troll Busters decided to bring an end to the lawsuit after it was informed by the court in September that it would fully dismiss the case unless Troll Busters could amend certain deficiencies in its complaint, such as the citation of specific instances of false marking, within 30 days (PCR Insider, 9/15/11).

Troll Busters had alleged that the companies — Roche Molecular Systems, Roche Applied Sciences, Roche Diagnostics, Clontech Laboratories, Integrated DNA Technologies, Life Technologies, Qiagen, Thermo Fisher Scientific, Quanta Biosciences, Gene Link, GenScript, EMD Chemicals, TriLink Bio Technologies, Cepheid, and Eurogentec — falsely marked various nucleic acid detection, amplification, and cloning technologies as being patented after the relevant patents expired.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.